You just read:

Nordic Nanovector: Promising Results from Preclinical Studies with a Novel CD37-targeted Alpha Therapy for B-cell Tumours to be Presented at ASH

News provided by

Nordic Nanovector

Nov 01, 2018, 09:39 ET